149 related articles for article (PubMed ID: 3065097)
1. Clinical applications of monoclonal antibodies against ovarian cancer-associated antigens.
Kenemans P; Yedema CA; Hilgers JH; Massuger LF; Verheijen RH; Thomas CM; Poels LG
Eur J Obstet Gynecol Reprod Biol; 1988 Nov; 29(3):207-18. PubMed ID: 3065097
[TBL] [Abstract][Full Text] [Related]
2. Strategies for the development of monoclonal antibodies for in vivo imaging: their use in the imaging of ovarian carcinoma.
Burchell J; Taylor-Papadimitriou J; Griffiths AB
Cancer Detect Prev Suppl; 1987; 1():241-7. PubMed ID: 3480054
[TBL] [Abstract][Full Text] [Related]
3. Mouse monoclonal antibodies to human epithelial differentiation antigens expressed on the surface of ovarian carcinoma ascites cells.
Mattes MJ; Look K; Furukawa K; Pierce VK; Old LJ; Lewis JL; Lloyd KO
Cancer Res; 1987 Dec; 47(24 Pt 1):6741-50. PubMed ID: 3677104
[TBL] [Abstract][Full Text] [Related]
4. Cell surface antigens of human ovarian and endometrial carcinoma defined by mouse monoclonal antibodies.
Mattes MJ; Cordon-Cardo C; Lewis JL; Old LJ; Lloyd KO
Proc Natl Acad Sci U S A; 1984 Jan; 81(2):568-72. PubMed ID: 6582512
[TBL] [Abstract][Full Text] [Related]
5. Development of two new monoclonal antibodies reactive to a surface antigen present on human ovarian epithelial cancer cells.
Xu FJ; Yu YH; Li BY; Moradi M; Elg S; Lane C; Carson L; Ramakrishnan S
Cancer Res; 1991 Aug; 51(15):4012-9. PubMed ID: 1855217
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibody against human ovarian tumor-associated antigens.
Poels LG; Peters D; van Megen Y; Vooijs GP; Verheyen RN; Willemen A; van Niekerk CC; Jap PH; Mungyer G; Kenemans P
J Natl Cancer Inst; 1986 May; 76(5):781-91. PubMed ID: 3517452
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies recognizing tumor-associated antigen of human ovarian mucinous cystadenocarcinomas.
Bhattacharya M; Chatterjee SK; Barlow JJ; Fuji H
Cancer Res; 1982 May; 42(5):1650-4. PubMed ID: 6175395
[TBL] [Abstract][Full Text] [Related]
8. Isolation and characterization of a monoclonal antibody, K1, reactive with ovarian cancers and normal mesothelium.
Chang K; Pastan I; Willingham MC
Int J Cancer; 1992 Feb; 50(3):373-81. PubMed ID: 1735605
[TBL] [Abstract][Full Text] [Related]
9. Serum levels and biochemical characteristics of human ovarian carcinoma-associated antigen defined by murine monoclonal antibody, CF511.
Ohkawa K; Tsukada Y; Murae M; Kimura E; Takada K; Abe T; Terashima Y; Mitani K
Br J Cancer; 1989 Dec; 60(6):953-60. PubMed ID: 2605105
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies for successful tumour imaging.
Burchell J; Taylor-Papadimitriou J; Granowska M; Britton K
Behring Inst Mitt; 1984 May; (74):87-93. PubMed ID: 6541035
[TBL] [Abstract][Full Text] [Related]
11. Epitope analysis of monoclonal antibody NCRC-11 defined antigen isolated from human ovarian and breast carcinomas.
Price MR; Edwards S; Powell M; Baldwin RW
Br J Cancer; 1986 Sep; 54(3):393-400. PubMed ID: 2428391
[TBL] [Abstract][Full Text] [Related]
12. CAR-3, a monoclonal antibody-defined antigen expressed on human carcinomas.
Prat M; Morra I; Bussolati G; Comoglio PM
Cancer Res; 1985 Nov; 45(11 Pt 2):5799-807. PubMed ID: 2413998
[TBL] [Abstract][Full Text] [Related]
13. Normal tissue reactivity of four anti-tumor monoclonal antibodies of clinical interest.
Stein R; Goldenberg DM; Mattes MJ
Int J Cancer; 1991 Jan; 47(2):163-9. PubMed ID: 1988361
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a new monoclonal antibody F4 detecting cell surface epitope and P-glycoprotein in drug-resistant human tumor cell lines.
Chu TM; Kawinski E; Lin TH
Hybridoma; 1993 Aug; 12(4):417-29. PubMed ID: 7503940
[TBL] [Abstract][Full Text] [Related]
15. [Characteristics and reactivities of a panel of monoclonal antibodies (McAbs) recognizing human colon cancer associated antigens].
Liu MP
Zhonghua Zhong Liu Za Zhi; 1992 Mar; 14(2):91-3. PubMed ID: 1618088
[TBL] [Abstract][Full Text] [Related]
16. Production and characterization of mouse monoclonal antibodies to human bladder tumor-associated antigens.
Young DA; Prout GR; Lin CW
Cancer Res; 1985 Sep; 45(9):4439-46. PubMed ID: 3896480
[TBL] [Abstract][Full Text] [Related]
17. [The diagnostic value of immunoscintigraphy using the monoclonal antibody OV-TL3 in patients with ovarian carcinoma].
Buist MR; Roos JC; Vermorken JB; Golding RP; Burger CW; Kenemans P
Ned Tijdschr Geneeskd; 1991 Jan; 135(4):126-30. PubMed ID: 2002855
[TBL] [Abstract][Full Text] [Related]
18. Three novel mouse monoclonal antibodies, OM-A, OM-B, and OM-C, reactive with mucinous type ovarian tumors.
Sakakibara K; Ueda R; Ohta M; Nakashima N; Tomoda Y; Takahashi T
Cancer Res; 1988 Aug; 48(16):4639-45. PubMed ID: 2456145
[TBL] [Abstract][Full Text] [Related]
19. Human monoclonal antibody for ovarian clear cell carcinoma-2, a human monoclonal antibody with antitumor activity against ovarian cancer cells that recognizes CA125-like antigen.
Suzuki N; Tamada Y; Shigirahara K; Suzuki A; Susumu N; Ishida I; Aoki D
Int J Gynecol Cancer; 2008; 18(5):996-1006. PubMed ID: 18028379
[TBL] [Abstract][Full Text] [Related]
20. Human class II antigens. Implication of carbohydrate in the determinants recognized by several antihuman class II monoclonal antibodies.
Sparrow RL; Vaughan HA; McKenzie IF
Transplantation; 1986 Dec; 42(6):647-52. PubMed ID: 2431525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
